Migden, M., Schmults, C., Khushalani, N., Guminski, A. ., Chang, A. L., Lewis, K. ., Ansstas, G. ., Bowyer, S. ., Hughes, B. ., Schadendorf, D. ., Modi, B. ., Dunn, L. ., Flatz, L. ., Hauschild, A. ., Yoo, S.-Y. ., Booth, J. ., Seebach, F. ., Lowy, I. ., Fury, M. . and Rischin, D. . (2023) “Phase 2 study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC): Final analysis from EMPOWER-CSCC-1 Groups 1, 2, and 3”, SKIN The Journal of Cutaneous Medicine, 7(2), p. s176. doi: 10.25251/skin.7.supp.176.